Semax combines a four-amino-acid segment of adrenocorticotropic hormone, or ACTH, with a proline–glycine–proline ending. It is a distinct synthetic peptide, rather than the entire hormone. This construction is the molecular identity described in the research papers highlighted here.12
In 2020, researchers used RNA sequencing to study gene activity in a rat model of brain ischaemia–reperfusion. At 24 hours, they reported 394 genes whose activity differed between Semax- and saline-treated rats, including patterns associated with inflammation and communication between nerve cells.1











